USD10
NTHI Shares
About NeOnc Technologies HldgsNeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

USD10
NTHI Shares
About NeOnc Technologies HldgsNeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Stats

TRADING WINDOW

Closed

OPENS AT

Not enough data

MARKET CAP

$91.28M

OPEN PRICE

$3.27

LOW (1Y)

$3.01

HIGH (1Y)

$12.99

LOW (24H)

$3.11

HIGH (24H)

$3.58

VOLUME (24H)

$70.97K

37.17%

Price history

Time
Price
Change
Today
$3.27
7.65%
1 Day
$3.46
1.73%
1 Week
$4.51
21.95%
1 Month
$5.46
35.53%
1 Year
$4.77
26.21%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.